Clinical Trial Update: Durvalumab ± Tremelimumab in Combination With Platinum Based Chemotherapy in Untreated Extensive-Stage Small Cell Lung Cancer (CASPIAN) [Phase 3]

View source ↗

Summary

Phase 3 CASPIAN trial update evaluating durvalumab with or without tremelimumab in combination with platinum-based chemotherapy for untreated extensive-stage sm…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Cisplatin or Carboplatin (platinum-based chemotherapy) (cisplatin / carboplatin)
• Durvalumab (Imfinzi) (durvalumab)
• Tremelimumab (tremelimumab)

Snippet

Sponsor: AstraZeneca | Conditions: Small Cell Lung Carcinoma Extensive Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING | Results posted: 2021-03-04